Bluejay Diagnostics, Inc. (BJDX)
Nasdaq: BJDX · Surgical & Medical Instruments & Apparatus · Acton, MA · filing with the SEC since 2017
Who runs Bluejay Diagnostics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Dey Indranil
President and CEO. First filing Nov 2021, latest Aug 18, 2026, 3 filings in all.
Officers reporting now
1
of 5 people with a filing in the last fifteen months
Directors reporting now
4
10 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Dey Indranil | President and CEO | Nov 2021 | Aug 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chase Donald R | director | Nov 2021 | Aug 18, 2026 | none |
| Dey Svetlana | director | Nov 2021 | Aug 18, 2026 | none |
| Wurth Douglas Clark | director | Nov 2021 | Aug 18, 2026 | none |
| Zeidman Fred S | director | Nov 2021 | Aug 18, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bank Of America Corp /de/ | 10% owner | Jul 2026 | Jul 22, 2026 | none |
| Bank Of America Na | 10% owner | Jul 2026 | Jul 22, 2026 | none |
| Bofa Securities, Inc. | 10% owner | Jul 2026 | Jul 22, 2026 | none |
| Hrt Financial LP | 10% owner | Jul 2026 | Jul 13, 2026 | 1 · $0.00 |
Earlier names on the record5, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.